DOI: 10.32098/mltj.02.2024.17

IS SARM – Selective Androgen Receptor Modulator: A Chance for Therapeutic Approach in Muscle-Wasting Chronic Conditions?

Authors

  • Alessandro Bartoli Department of Musculoskeletal Disorders, Faculty of Medicine and Surgery, University of Salerno, Baronissi, Italy; Orthopedic Clinic, “San Giovanni di Dio e Ruggi d’Aragona” Hospital, Salerno, Italy
  • Nicola Maffulli Queen Mary University of London, Barts and the London School of Medicine and Dentistry, Centre for Sports and Exercise Medicine, Mile End Hospital, London, U.K.; Faculty of Medicine, School of Pharmacy and Bioengineering, Guy Hilton Research Centre, Keele University, Stoke-on-Trent, U.K; Department of Trauma and Orthopaedic Surgery, Faculty of Medicine and Psychology, University La Sapienza, Rome, Italy
  • Gabriella Oliva Department of Internal Medicine, Ospedale del Mare, ASL NA1 Centro, Naples, Italy
  • Salvatore Ziello Department of Musculoskeletal Disorders, Faculty of Medicine and Surgery, University of Salerno, Baronissi, Italy; Orthopedic Clinic, “San Giovanni di Dio e Ruggi d’Aragona” Hospital, Salerno, Italy
  • Francesco Oliva Department of Human Sciences and Promotion of the Quality of Life, San Raffaele Roma Open University, Rome, Italy

olivafrancesco@hotmail.com

Keywords

cachexia, muscle-wasting, sarcopenia, SARM, SERM

Abstract

Purpose of review. The purpose of this paper is to review the current concepts regard­ing a new-old pharmacological class, SARM (Selective Androgen Receptor Modula­tor). Especially how SARM can be beneficial in treatment of orthopedic disease.

Materials and methods. Androgens (testosterone and dihydrotestosterone (DHT)) are the male sex hormones required for development of the male reproductive system and secondary sexual characteristics. SARMs due to ability to bind androgen receptor are excellent in treatment of various diseases.

Discussion. Based on the published literature, a review has been carried out on SARM and its fields of application in the treatment of muscle wasting pathologies. Starting from the history of the SARMs, its role in prevention of muscle wasting, anabolic effects and side effects were addressed.

Conclusions. Nonsteroidal SARMs are unique in their ability to bind the androgen receptor with high affinity and exhibit tissue selective activity. SARMs can be used to treat muscle wasting conditions, osteoporosis, frailty syndrome without unwanted side effects associated with androgens.

View the entire article

Downloads

This article was originally published by Edra S.p.A. and is made available here as part of the Muscles, Ligaments and Tendons Journal archive. Its inclusion in the current Journal archive does not alter the copyright, licensing, or reuse terms applicable at the time of its original publication.

Published

2024-06-30

How to Cite

1.
Bartoli A, Maffulli N, Oliva G, Ziello S, Oliva F. IS SARM – Selective Androgen Receptor Modulator: A Chance for Therapeutic Approach in Muscle-Wasting Chronic Conditions? MLTJ [Internet]. 2024 Jun. 30 [cited 2026 Nov. 20];14(2). Available from: https://mltj.online/index.php/mltj/article/view/6407

Most read articles by the same author(s)

1 2 > >>